Literature DB >> 18178849

TNF-alpha antagonism generates a population of antigen-specific CD4+CD25+ T cells that inhibit protective immunity in murine histoplasmosis.

George S Deepe1, Reta S Gibbons.   

Abstract

In both humans and mice, treatment with TNF-alpha antagonists is associated with serious infectious complications including disseminated histoplasmosis. The mechanisms by which inhibition of endogenous TNF-alpha alter protective immunity remain obscure. Herein, we tested the possibility that neutralization of this cytokine triggered the emergence of T cells that dampen immunity. The lungs of mice given mAb to TNF-alpha contained a higher proportion and number of CD4+CD25+ cells than controls. This elevation was not observed in IFN-gamma- or GM-CSF-deficient mice or in those given a high inoculum. Phenotypic analysis revealed that these cells lacked many of the characteristics of natural regulatory T cells, including Foxp3. CD4+CD25+ cells from TNF-alpha-neutralized mice suppressed Ag-specific, but not nonspecific, responses in vitro. Elimination of CD25+ cells in vivo restored protective immunity in mice given mAb to TNF-alpha and adoptive transfer of CD4+CD25+ cells inhibited immunity. In vitro and in vivo, the suppressive effect was reversed by mAb to IL-10. Thus, neutralization of TNF-alpha is associated with the induction of a population of regulatory T cells that alter protective immunity in an Ag-specific manner to Histoplasma capsulatum.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178849      PMCID: PMC2447823          DOI: 10.4049/jimmunol.180.2.1088

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  66 in total

1.  Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP.

Authors:  Wanda Niedbala; Xiao-Qing Wei; Carol Campbell; Duncan Thomson; Mousa Komai-Koma; Foo Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-25       Impact factor: 11.205

2.  Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept.

Authors:  Jong-Hoon Lee; Nancy R Slifman; Sharon K Gershon; Evelyne T Edwards; William D Schwieterman; Jeffrey N Siegel; Robert P Wise; S Lori Brown; John N Udall; M Miles Braun
Journal:  Arthritis Rheum       Date:  2002-10

3.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

Authors:  Yasmine Belkaid; Ciriaco A Piccirillo; Susana Mendez; Ethan M Shevach; David L Sacks
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

Review 4.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

6.  Low responsiveness to IFN-gamma, after pretreatment of mouse macrophages with lipopolysaccharides, develops via diverse regulatory pathways.

Authors:  Ana Crespo; Michael B Filla; William J Murphy
Journal:  Eur J Immunol       Date:  2002-03       Impact factor: 5.532

7.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

8.  Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy.

Authors:  Karen L Wood; Chadi A Hage; Kenneth S Knox; Martin B Kleiman; Aruna Sannuti; Richard B Day; L Joseph Wheat; Homer L Twigg
Journal:  Am J Respir Crit Care Med       Date:  2003-02-13       Impact factor: 21.405

9.  Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice.

Authors:  Ava J Wu; Hong Hua; Sibyl H Munson; Hugh O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

Review 10.  The role of CD4(+)CD25(+) regulatory T cells in Leishmania infection.

Authors:  Yasmine Belkaid
Journal:  Expert Opin Biol Ther       Date:  2003-09       Impact factor: 4.388

View more
  18 in total

Review 1.  The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on CD4(+) FoxP3(+) regulatory T cells.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  Immunology       Date:  2011-06-02       Impact factor: 7.397

Review 2.  Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  FEBS Lett       Date:  2011-04-15       Impact factor: 4.124

3.  CCR5 deficiency mitigates the deleterious effects of tumor necrosis factor α antagonism in murine histoplasmosis.

Authors:  Danielle N Kroetz; George S Deepe
Journal:  J Infect Dis       Date:  2012-01-23       Impact factor: 5.226

Review 4.  Regulatory T cells in rheumatoid arthritis.

Authors:  Sujata Sarkar; David A Fox
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

Review 5.  Adaptive immunity to fungi.

Authors:  Akash Verma; Marcel Wüthrich; George Deepe; Bruce Klein
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-06       Impact factor: 6.915

Review 6.  The role of cytokines and chemokines in Histoplasma capsulatum infection.

Authors:  Danielle N Kroetz; George S Deepe
Journal:  Cytokine       Date:  2011-08-26       Impact factor: 3.861

7.  Role of TNFalpha in early chemokine production and leukocyte infiltration into heart allografts.

Authors:  D Ishii; A D Schenk; S Baba; R L Fairchild
Journal:  Am J Transplant       Date:  2009-12-02       Impact factor: 8.086

Review 8.  Histoplasma capsulatum at the host-pathogen interface.

Authors:  Joshua D Nosanchuk; Attila Gacser
Journal:  Microbes Infect       Date:  2008-07-10       Impact factor: 2.700

Review 9.  Histoplasma capsulatum, lung infection and immunity.

Authors:  Michael C Horwath; Roger A Fecher; George S Deepe
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

Review 10.  Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literature.

Authors:  Sima S Toussi; Nancy Pan; Heather M Walters; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2013-07-29       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.